Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice
- 1 March 1978
- journal article
- research article
- Published by Springer Nature in Journal Of Neural Transmission-Parkinsons Disease and Dementia Section
- Vol. 42 (1) , 37-43
- https://doi.org/10.1007/bf01262727
Abstract
Each of six kynurenines tested (DL-kynurenine, quinolinic, 3-hydroxy-anthranilic, xanthurenic, picolinic, and nicotinic acids) injected into brain ventricles in mice in doses of 25–50 mcg produced motor excitement and/or clonic convulsions. Anthranilic acid did not produce these effects. The strongest metabolite was quinolinic acid, which was active in a dose of 1 mcg. It was also the only compound which produced motor excitement and convulsions after intraperitoneal injection (in doses of 400–600 mg/kg,i.e. 10,000–15,000 mcg per mouse). The hypothermic effect of intraventricularly-injected kynurenines was roughly similar to that of intraperitoneally-injected material at 100–1000 times higher doses. These data suggest poor penetration of kynurenines formed in the liver into the brain, and the possible involvement of these metabolites of tryptophan (particularly if they are formed inside the brain) in the mechanism of seizures.This publication has 7 references indexed in Scilit:
- BEHAVIOURAL CHANGES INDUCED IN CONSCIOUS MICE BY INTRACEREBROVENTRICULAR INJECTION OF CATECHOLAMINES, ACETYLCHOLINE AND 5‐HYDROXYTRYPTAMINEBritish Journal of Pharmacology, 1975
- Relationship of brain monoamine and locomotor activity in ratsBiochemical Pharmacology, 1975
- Cerebral tryptophan‐2,3‐dioxygenase (pyrrolase) and its induction in rat brainJournal of Neurochemistry, 1974
- Kynurenines as Probable Participants of DepressionPharmacopsychiatry, 1973
- Interaction of kynurenine and its metabolites with tryptamine, serotonin and its precursors and oxotremorinePsychopharmacology, 1972
- A Note on an Apparatus for Intracerebral Injections in Conscious Mice**Received November 2, 1959, from the Faculty of Pediatrics, Charles University, Prague, CzechoslovakiaJournal of the American Pharmaceutical Association (Scientific ed.), 1960